Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients

The present study evaluated the efficacy and safety of maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in patients with metastatic non-small cell lung cancer. The overall response rate in the docetaxel-cisplatin  phase was 30.4%, with complete response...

Full description

Bibliographic Details
Main Authors: Meiyu Fang, Shengye Wang, Yabing Zheng, Xiangmin Kong, Liyan Gong, Youhao Qiu, Yazhen Zhao, Weimin Mao
Format: Article
Language:English
Published: Bangladesh Pharmacological Society 2012-09-01
Series:Bangladesh Journal of Pharmacology
Subjects:
Online Access:https://www.banglajol.info/index.php/BJP/article/view/11656